Register Now

Biocon Biologics gets UK drug regulator nod for Denosumab biosimilars — Vevzuo and Evfraxy

Clinical studies have demonstrated that both biosimilars are comparable in safety and efficacy to the reference product, the company stated.

Leave a Reply

Your email address will not be published. Required fields are marked *